LMAG presentation
02/08/2022 IRLA’s board director Paul Corver said “I was pleased to be asked to participate on a panel discussing all aspects of legacy and presenting to the London Market Actuaries Group. Even more pleased to have done this in person......More
Clyde & Co
20/07/2022 NICE approves use of nivolumab and ipilimumab as first-line treatment for mesothelioma...More
